Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amicus therapeutics
biogen
biotech
boston blog main
boston top stories
2
×
boulder/denver blog main
boulder/denver top stories
crispr therapeutics
detroit blog main
detroit top stories
gene therapy
glaxosmithkline
indiana blog main
2
×
indiana top stories
life sciences
medicare
messenger rna
national
national blog main
2
×
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
abbvie
ad-comm
adverum biotechnologies
affimed
What
bio
crispr
2
×
roundup
acquisitions
albert
allogene
biggest
bourla
cancer
ceo
company
diversity
drug
future
hot
immunotherapy
imports
investors
ipo
juno
maker
maps
measured
million
nearly
new
patients
pfizer
pfizer’s
remains
revenue
shares
snapped
therapeutics
ticket
today
utero
world’s
years
Language
unknown
Current search:
novartis
×
crispr
×
" boston top stories "
×
" indiana blog main "
×
" national blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More